Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
10 December, 2018 03:19 IST
Lupin launches generic Clobetasol propionate ointment in US
Source: IRIS | 10 Oct, 2018, 09.59AM
Comments  |  Post Comment

Pharma major Lupin announced the launch of Clobetasol Propionate Ointment USP 0.05%, having received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin's Clobetasol Propionate Ointment USP, 0.05% is the generic equivalent of Fougera Pharmaceuticals Inc.'s Temovate Ointment, 0.05%. It is a super-high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Clobetasol Propionate Ointment USP 0.05% had annual sales of approximately USD 93.4 million in the US (IQVIA MAT June 2018).

Shares of the company gained Rs 13.7, or 1.58%, to trade at Rs 879.20. The total volume of shares traded was 23,154 at the BSE (9.49 a.m., Wednesday).



Lupin Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
HCL Tech to acquire select IBM Software products for USD 1.8 bn - 07-Dec-2018 10:08
Wipro, Alfresco expand pact to offer digital transformation capabilities - 07-Dec-2018 09:59
Indian Hume Pipe Co receives contract worth Rs 2.04 bn - 06-Dec-2018 09:50
Infosys inaugurates technology and innovation hub in Hartford - 06-Dec-2018 09:46
USFDA completes inspection of Lupin's Mandideep location - 05-Dec-2018 15:31
NTPC wins 85MW solar projects in UPNEDA's solar tender - 05-Dec-2018 15:03
Alembic Pharma gets USFDA nod for Candesartan Cilexetil tablets - 05-Dec-2018 13:05
Kridhan Infra's associate Co bags orders worth Rs 1.05 bn - 05-Dec-2018 10:06
Lupin launches generic Silodosin capsules in United States - 05-Dec-2018 09:54
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer